+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 70Years
All Genders
ID06087614

Phase II Randomized Study of Hypoxia-Adjusted Radiotherapy Dose Escalation Using 18F FMISO PET CT in Head and Neck Squamous Cell Carcinoma

Led by Rajiv Gandhi Cancer Institute & Research Center, India · Updated on 2025-01-17

124

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying head and neck squamous cell carcinoma to understand how increasing radiation doses to low-oxygen hypoxic areas within tumors affects cancer control, treatment feasibility, and side effects. This phase II trial compares different radiation approaches combined with standard chemotherapy using cisplatin. The goal is to improve locoregional control of the cancer while monitoring safety. Participants undergo imaging with 18F FMISO PET scans to identify tumor oxygen levels. Those without hypoxia receive standard chemoradiation, while patients with hypoxia are randomized to either standard chemoradiation or an escalated radiation dose targeted to hypoxic tumor areas using advanced planning techniques. Radiation is delivered in daily fractions over several weeks with concurrent weekly cisplatin chemotherapy. The higher dose group receives an additional boost of 10 Gy to the hypoxic sub-volumes. Throughout the study, participants will have repeated imaging and assessments to adjust treatment volumes and monitor response. Researchers will evaluate locoregional control over 24 months, along with survival and relapse-free survival. Safety and treatment tolerability will also be followed. The total participation spans the treatment period and follow-up assessments up to two years to measure outcomes and side effects.

CONDITIONS

Brief Title

Dose Escalation Using Hypoxia-adjusted Radiotherapy

Research Team

S

Sarthak Tandon, DNB

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here